INSERM U958, Centre National de Génotypage, 2 rue Gaston Crémieux, Evry, France.
Genes Immun. 2009 Dec;10 Suppl 1(Suppl 1):S121-7. doi: 10.1038/gene.2009.99.
Candidate gene studies have long been the principal method for identification of susceptibility genes for type I diabetes (T1D), resulting in the discovery of HLA, INS, PTPN22, CTLA4, and IL2RA. However, many of the initial studies that relied on this strategy were largely underpowered, because of the limitations in genomic information and genotyping technology, as well as the limited size of available cohorts. The Type I Diabetes Genetic Consortium (T1DGC) has established resources to re-evaluate earlier reported genes associated with T1D, using its collection of 2298 Caucasian affected sib-pair families (with 11 159 individuals). A total of 382 single-nucleotide polymorphisms (SNPs) located in 21 T1D candidate genes were selected for this study and genotyped in duplicate on two platforms, Illumina and Sequenom. The genes were chosen based on published literature as having been either 'confirmed' (replicated) or not (candidates). This study showed several important features of genetic association studies. First, it showed the major impact of small rates of genotyping errors on association statistics. Second, it confirmed associations at INS, PTPN22, IL2RA, IFIH1 (earlier confirmed genes), and CTLA4 (earlier confirmed, with distinct SNPs) loci. Third, it did not find evidence for an association with T1D at SUMO4, despite confirmed association in Asian populations, suggesting the potential for population-specific gene effects. Fourth, at PTPN22, there was evidence for a novel contribution to T1D risk, independent of the replicated effect of the R620W variant. Fifth, among the candidate genes selected for replication, the association of TCF7-P19T with T1D was newly replicated in this study. In summary, this study was able to replicate some genetic effects, reject others, and provide suggestions of association with several of the other candidate genes in stratified analyses (age at onset, HLA status, population of origin). These results have generated additional interesting functional hypotheses that will require further replication in independent cohorts.
候选基因研究一直是鉴定 1 型糖尿病 (T1D) 易感基因的主要方法,导致了 HLA、INS、PTPN22、CTLA4 和 IL2RA 的发现。然而,许多最初依赖于这种策略的研究由于基因组信息和基因分型技术的限制以及可用队列的大小有限,因此在很大程度上没有足够的效力。1 型糖尿病遗传联盟 (T1DGC) 已经建立了资源,以使用其收集的 2298 个白种人受影响的同胞对家庭(共 11159 人),重新评估与 T1D 相关的早期报道基因。选择了 21 个 T1D 候选基因中的 382 个单核苷酸多态性 (SNP) 进行这项研究,并在两个平台(Illumina 和 Sequenom)上进行了两次重复基因分型。这些基因是根据文献中已被“证实”(复制)或未被“证实”(候选)的基因选择的。这项研究显示了遗传关联研究的几个重要特征。首先,它显示了基因分型错误率对关联统计的重大影响。其次,它证实了 INS、PTPN22、IL2RA、IFIH1(早期证实的基因)和 CTLA4(早期证实的,具有不同的 SNP)基因座的关联。第三,尽管亚洲人群的研究已经证实了 SUMO4 与 T1D 的关联,但在该研究中没有发现与 T1D 相关的证据,这表明可能存在特定于人群的基因效应。第四,在 PTPN22 中,存在与 R620W 变体的重复效应无关的 T1D 风险的新贡献的证据。第五,在选择用于复制的候选基因中,TCF7-P19T 与 T1D 的关联在本研究中首次被复制。综上所述,本研究能够复制一些遗传效应,拒绝其他遗传效应,并在分层分析中提供与其他几个候选基因关联的建议(发病年龄、HLA 状态、起源人群)。这些结果产生了其他有趣的功能假设,这些假设需要在独立队列中进一步复制。